These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15317623)

  • 61. NIH report.
    Makulowich GS
    AIDS Patient Care STDS; 1998 Feb; 12(2):151. PubMed ID: 11361922
    [No Abstract]   [Full Text] [Related]  

  • 62. An Innovative Syringe Exchange Program.
    Potera C
    Am J Nurs; 2017 Jul; 117(7):17. PubMed ID: 28644276
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Critical condition facing needle exchange programs: the politics of science.
    Sherman SG
    Subst Use Misuse; 2006; 41(6-7):827-9. PubMed ID: 16809169
    [No Abstract]   [Full Text] [Related]  

  • 64. Thinking ethically about needle and syringe programs.
    Kleinig J
    Subst Use Misuse; 2006; 41(6-7):815-25. PubMed ID: 16809168
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey.
    Day CA; Topp L; Iversen J; Maher L;
    Drug Alcohol Rev; 2008 Sep; 27(5):559-61. PubMed ID: 18608447
    [No Abstract]   [Full Text] [Related]  

  • 66. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.
    Bluthenthal RN; Ridgeway G; Schell T; Anderson R; Flynn NM; Kral AH
    Addiction; 2007 Apr; 102(4):638-46. PubMed ID: 17286637
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Injection centers--new international experiences and Norwegian political debate].
    Gjesdal S
    Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2785-7. PubMed ID: 15534677
    [No Abstract]   [Full Text] [Related]  

  • 68. Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programs.
    Kuyper LM; Kerr T; Li K; Hogg RS; Tyndall MW; Montaner JS; Wood E
    Subst Use Misuse; 2006; 41(6-7):883-99. PubMed ID: 16809177
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The invisible IDU.
    Raymond D
    GMHC Treat Issues; 2005; 19(5-6):16. PubMed ID: 16193580
    [No Abstract]   [Full Text] [Related]  

  • 71. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes.
    Bruneau J; Daniel M; Kestens Y; Zang G; Généreux M
    J Epidemiol Community Health; 2008 Sep; 62(9):804-10. PubMed ID: 18701731
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Threat or opportunity? Secondary exchange in a setting with widespread availability of needles.
    Lenton S; Bevan J; Lamond T
    Subst Use Misuse; 2006; 41(6-7):845-64. PubMed ID: 16809175
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Can outreach work?
    Morrison CL; Ruben SM
    Addiction; 1995 Oct; 90(10):1401-4. PubMed ID: 8616469
    [No Abstract]   [Full Text] [Related]  

  • 74. Emerging role of supervised injecting facilities in human immunodeficiency virus prevention.
    Milloy MJ; Wood E
    Addiction; 2009 Apr; 104(4):620-1. PubMed ID: 19335659
    [No Abstract]   [Full Text] [Related]  

  • 75. Expanded syringe access demonstration program in New York State: an intervention to prevent HIV/AIDS transmission.
    Klein SJ; Birkhead GS; Candelas AR
    J Urban Health; 2000 Dec; 77(4):762-7. PubMed ID: 11194315
    [No Abstract]   [Full Text] [Related]  

  • 76. Injection drug use in Rural Iran: integrating HIV prevention into iran's rural primary health care system.
    Mojtahedzadeh V; Razani N; Malekinejad M; Vazirian M; Shoaee S; Saberi Zafarghandi MB; Hernandez AL; Mandel JS
    AIDS Behav; 2008 Jul; 12(4 Suppl):S7-12. PubMed ID: 18521737
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.
    Islam M; Wodak A; Conigrave KM
    Int J Drug Policy; 2008 Dec; 19(6):436-41. PubMed ID: 17766100
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Syringe exchange programs in Brazil: preliminary assessment of 45 programs.
    Fonseca EM; Ribeiro JM; Bertoni N; Bastos FI
    Cad Saude Publica; 2006 Apr; 22(4):761-70. PubMed ID: 16612430
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Policy watch. Turning op-ed into policy.
    Gebbie KM
    AIDS Read; 2006 Sep; 16(9):453-4. PubMed ID: 17024763
    [No Abstract]   [Full Text] [Related]  

  • 80. Condom attitudes and behaviors among injection drug users participating in California syringe exchange programs.
    Bogart LM; Kral AH; Scott A; Anderson R; Flynn N; Gilbert ML; Bluthenthal RN
    AIDS Behav; 2005 Dec; 9(4):423-32. PubMed ID: 16249946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.